---
layout: post
title: "Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP"
date: 2026-02-19T01:49:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/ultragenyx-pharmaceutical-inc-rare-investors-april-6-2026-filing-deadline-in-securities-fraud-class-action---contact-kessler-topaz-meltzer--check-llp-302692074.html
significance: 9.00
---

<p>Did you buy RARE common stock between August 3, 2023, and December 26, 2025? Affected Ultragenyx Pharmaceutical Inc. Investor Summary Who: Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) What: Securities fraud class action lawsuit filed Class Period: August 3, 2023, through December 26,...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/ultragenyx-pharmaceutical-inc-rare-investors-april-6-2026-filing-deadline-in-securities-fraud-class-action---contact-kessler-topaz-meltzer--check-llp-302692074.html)

**Published:** 2026-02-19 01:49:00 +0000

**Significance Score:** 9.00

[View original](https://www.prnewswire.com/news-releases/ultragenyx-pharmaceutical-inc-rare-investors-april-6-2026-filing-deadline-in-securities-fraud-class-action---contact-kessler-topaz-meltzer--check-llp-302692074.html)
